| Bioactivity | BACE1 (485-501) is the carboxyl terminal of BACE1 (Beta-site APP cleaving enzyme 1). BACE1 (485-501) can be used as antigen to produce anti-BACE1-C antibody[1]. |
| Name | BACE1 (485-501) |
| CAS | 300584-87-6 |
| Sequence | Cys-Leu-Arg-Gln-Gln-His-Asp-Asp-Phe-Ala-Asp-Asp-Ile-Ser-Leu-Leu-Lys |
| Shortening | CLRQQHDDFADDISLLK |
| Formula | C86H137N25O29S |
| Molar Mass | 2017.22 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Harada H, et al. Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains. Neurosci Res. 2006 Jan;54(1):24-9. |
BACE1 (485-501)
CAS: 300584-87-6 F: C86H137N25O29S W: 2017.22
BACE1 (485-501) is the carboxyl terminal of BACE1 (Beta-site APP cleaving enzyme 1). BACE1 (485-501) can be used as anti
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.